Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 6
1984 5
1985 6
1986 8
1987 14
1988 2
1989 5
1990 2
1991 3
1992 2
1993 2
1994 1
1995 1
1997 1
1999 4
2000 2
2001 7
2002 1
2004 2
2005 1
2006 2
2007 1
2008 2
2009 1
2013 2
2014 3
2015 1
2016 1
2017 1
2018 1
2020 3
2023 1
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nifedipine a gnaud trial (3,592 results)?
State-of-the-art evidence in the treatment of systemic sclerosis.
Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. Pope JE, et al. Nat Rev Rheumatol. 2023 Apr;19(4):212-226. doi: 10.1038/s41584-023-00909-5. Epub 2023 Feb 27. Nat Rev Rheumatol. 2023. PMID: 36849541 Free PMC article. Review.
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous SSc (dcSSc) and the use of organ-specific therapies, has improved, as evident from randomize …
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ involvement, fibrosis and vasculopathy. Trea …
Raynaud disease.
Butendieck RR, Murray PM. Butendieck RR, et al. J Hand Surg Am. 2014 Jan;39(1):121-4. doi: 10.1016/j.jhsa.2013.08.117. Epub 2013 Nov 6. J Hand Surg Am. 2014. PMID: 24211176 Review. No abstract available.
Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
Smith CD, McKendry RJ. Smith CD, et al. Lancet. 1982 Dec 11;2(8311):1299-301. doi: 10.1016/s0140-6736(82)91508-2. Lancet. 1982. PMID: 6128596 Clinical Trial.
17 patients with moderate to severe Raynaud's phenomenon were entered into a 6 week randomised double-blind crossover study to compare the efficacy of nifedipine with that of placebo. ...Patients gave nifedipine a significantly higher drug-effectivenes …
17 patients with moderate to severe Raynaud's phenomenon were entered into a 6 week randomised double-blind crossover study to …
A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
Corbin DO, Wood DA, Macintyre CC, Housley E. Corbin DO, et al. Eur Heart J. 1986 Feb;7(2):165-70. doi: 10.1093/oxfordjournals.eurheartj.a062040. Eur Heart J. 1986. PMID: 3516704 Clinical Trial.
During three winter months, 23 women participated in a double blind placebo controlled cross-over clinical trial of nifedipine in the treatment of Raynaud's phenomenon. Nifedipine and placebo were given in random order for two consecutive …
During three winter months, 23 women participated in a double blind placebo controlled cross-over clinical trial of nifedip …
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Ettinger WH, Wise RA, Schaffhauser D, Wigley FM. Ettinger WH, et al. Am J Med. 1984 Sep;77(3):451-6. doi: 10.1016/0002-9343(84)90101-3. Am J Med. 1984. PMID: 6540986 Clinical Trial.
The prostaglandin thromboxane A2 causes platelet aggregation and vasoconstriction and may be important in the pathogenesis of Raynaud's phenomenon. Therefore, a randomized, double-blind, placebo-controlled trial was conducted to assess the effectiveness of da …
The prostaglandin thromboxane A2 causes platelet aggregation and vasoconstriction and may be important in the pathogenesis of Raynaud …
Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up.
[No authors listed] [No authors listed] Arch Intern Med. 2000 Apr 24;160(8):1101-8. doi: 10.1001/archinte.160.8.1101. Arch Intern Med. 2000. PMID: 10789602 Clinical Trial.
BACKGROUND: The efficacy and safety of sustained-release nifedipine for the treatment of primary Raynaud phenomenon (RP) has not previously been demonstrated by a randomized, controlled trial. ...PARTICIPANTS AND METHODS: This is a randomized, controlled c …
BACKGROUND: The efficacy and safety of sustained-release nifedipine for the treatment of primary Raynaud phenomenon (RP) has n …
Nifedipine for Raynaud's phenomenon.
[No authors listed] [No authors listed] Lancet. 1983 Jan 15;1(8316):130. Lancet. 1983. PMID: 6129447 Clinical Trial. No abstract available.
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Meyrick Thomas RH, Rademaker M, Grimes SM, MacKay A, Kovacs IB, Cook ED, Bowcock SM, Kirby JD. Meyrick Thomas RH, et al. Br J Dermatol. 1987 Aug;117(2):237-41. doi: 10.1111/j.1365-2133.1987.tb04122.x. Br J Dermatol. 1987. PMID: 3307894 Clinical Trial.
A double-blind, placebo-controlled, cross-over trial of nifedipine 10 mg three times daily for 6 weeks, in 10 patients with Raynaud's phenomenon secondary to systemic sclerosis, is reported. A significant reduction in the duration of attacks of Rayn …
A double-blind, placebo-controlled, cross-over trial of nifedipine 10 mg three times daily for 6 weeks, in 10 patients with …
Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL. Gjørup T, et al. Am Heart J. 1986 Apr;111(4):742-5. doi: 10.1016/0002-8703(86)90109-2. Am Heart J. 1986. PMID: 3513504 Clinical Trial.
Twenty-six patients with idiopathic Raynaud's phenomenon participated in a double-blind, crossover clinical trial comparing the clinical effect of nifedipine with that of placebo. ...Nifedipine proved to be effective in the treatme …
Twenty-six patients with idiopathic Raynaud's phenomenon participated in a double-blind, crossover clinical trial …
97 results